OUTCOME OF MULTIMODALITY TREATMENT WITH RADICAL PROSTATECTOMY AS INITIAL STEP FOR PROSTATE CANCER WITH PSA >20 NG/ML: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 801 PATIENTS

被引：0
|
作者：
Spahn, Martin
Gontero, Paolo
Joniau, Steven
Tombal, Bertrand
Bangma, Chris H.
Waz, Jochen
Eeckt, Kathy Vander
Bader, Pia
Hsu, Chao-Yu
Marchioro, Giansilvio
Isbarn, Hendrik
Frohneberg, Detlef
Graefen, Markus
Schroder, Fritz H.
Tizzani, Alessandro
Van Cangh, Paul
Van Poppel, Hein
机构：
来源：
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(09)61293-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1279
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [1] Outcome of prostate cancer patients with initial PSA≥ 20 ng/ml undergoing radical prostatectomy
    Zweryel, Ulrike
    Suttmann, Henrik
    Schroeder, Thomas
    Siemer, Stefan
    Wullich, Bernd
    Kamradt, Joern
    Lehmann, Jan
    Stoeckle, Michael
    [J]. EUROPEAN UROLOGY, 2007, 52 (04) : 1058 - 1066
  • [2] OUTCOME OF MULTIMODALITY TREATMENT OF CLINICALLY LOCALLY ADVANCED PROSTATE CANCER WITH RADICAL PROSTATECTOMY AS INITIAL STEP: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 895 PATIENTS
    Gontero, P.
    Spahn, M.
    Joniau, S. G.
    Tombal, B.
    Bangma, C.
    Walz, J.
    Hsu, C. Y.
    Van Der Eeckt, K.
    Marchioro, G.
    Bader, P.
    Frohneberg, D.
    Graefen, M.
    Huland, H.
    Schroder, F.
    Tizzani, A.
    Van Cangh, P.
    Van Poppel, H.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 251 - 251
  • [3] OUTCOME OF MULTIMODALITY TREATMENT OF HIGH-RISK LOCALIZED PROSTATE CANCER (CT3-4 OR PSA ≥20 NG/ML OR BIOPSY GLEASON SCORE ≥8) WITH RADICAL PROSTATECTOMY AS INITIAL STEP: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 1413 PATIENTS
    Joniau, S. G.
    Spahn, M.
    Gontero, P.
    Tombal, B.
    Bangma, C.
    Walz, J.
    Hsu, C. Y.
    Van Der Eeckt, K.
    Marchioro, G.
    Bader, P.
    Frohneberg, D.
    Graefen, M.
    Huland, H.
    Schroder, F.
    Tizzani, A.
    Van Cangh, P.
    Van Poppel, H.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 252 - 252
  • [4] Outcome of multimodality treatment of high-risk localized prostate cancer (cT3-4 OR PSA ≥20 ng/ml OR biopsy Gleason score ≥8) with radical prostatectomy as initial step: a multi-institutional outcome study of 1413 patients
    Spahn, M.
    Gontero, P.
    Tombal, B.
    Bangma, C.
    Walz, J.
    Hsu, C. Y.
    van der Eeckt, K.
    Marchioro, G.
    Bader, P.
    Frohneberg, D.
    Graefen, M.
    Huland, H.
    Schroder, F.
    Tizzani, A.
    van Cangh, P.
    van Poppel, H.
    Joniau, S. G.
    [J]. ONKOLOGIE, 2010, 33 : 89 - 90
  • [5] OUTCOME OF MULTIMODALITY TREATMENT OF HIGH-RISK LOCALIZED PROSTATE CANCER (CT3-4 OR PSA ≥20 NG/ML OR BIOPSY GLEASON SCORE ≥8) WITH RADICAL PROSTATECTOMY AS INITIAL STEP: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 1413 PATIENTS
    Joniau, Steven
    Spahn, Martin
    Gontero, Paolo
    Tombal, Bertrand
    Bangma, Chris H.
    Waz, Jochen
    Hsu, Chao-Yu
    Vander Eeckt, Kathy
    Marchioro, Giansilvio
    Bader, Pia
    Isbarn, Hendrik
    Frohneberg, Detlef
    Graefen, Markus
    Schroeder, Fritz H.
    Tizzani, Alessandro
    Van Cangh, Paul
    Van Poppel, Hein
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 574 - 575
  • [6] PROSTATE CANCER WITH INITIAL PSA ≥ 20 NG/ML: OUTCOME AFTER RADICAL PROSTATECTOMY WITH AND WITHOUT IMMEDIATE HORMONAL THERAPY
    Zwergel, Ulrike E.
    Kamradt, Joern
    Ohlmann, Carsten
    Becker, Frank
    Lehmann, Jan
    Stoeckle, Michael
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 576 - 577
  • [7] PREDICTING PROSTATE CANCER SPECIFIC OUTCOME AFTER RADICAL PROSTATECTOMY AMONG MEN WITH PSA &[GE] 20 NG/ML WITH OR WITHOUT ADDITIONAL HIGH RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 712 PATIENTS
    Spahn, Martin
    Gontero, Paolo
    Kneitz, Burkhard
    Tombal, Bertrand
    Hsu, Belgium C-J
    Van der Eeckt, Kathie
    Marchioro, Giansilvio
    Bader, Pia
    Frohneberg, Detlef
    Van Poppel, Hein
    Joniau, Steven
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E227 - E227
  • [8] Outcome of prostate cancer patients with initial PSA ≥ 20 ng/ml after radical prostatectomy:: Results with and without immediate hormonal therapy
    Zwergel, U. E.
    Kamradt, J.
    Hack, M.
    Suttmann, H.
    Lehmann, J.
    Stoeckle, M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 103 - 103
  • [9] PREDICTING PROSTATE CANCER SPECIFIC OUTCOME AMONG MEN WITH PSA ≥ 20 NG/ML AND MULTIPLE UNFAVOURABLE RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 712 PATIENTS
    Spahn, M.
    Gontero, P.
    Kneitz, B.
    Tombal, B.
    Hsu, C. Y.
    Van Der, K.
    Marchiori, G.
    Bader, P.
    Frohneberg, D.
    Tizzani, A.
    Van Poppel, H.
    Joniau, S.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 267 - 267
  • [10] Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
    Spahn, Martin
    Joniau, Steven
    Gontero, Paolo
    Fieuws, Steffen
    Marchioro, Giansilvio
    Tombal, Bertrand
    Kneitz, Burkhard
    Hsu, Chao-Yu
    Van der Eeckt, Katie
    Bader, Pia
    Frohneberg, Detlef
    Tizzani, Alessandro
    Van Poppel, Hein
    [J]. EUROPEAN UROLOGY, 2010, 58 (01) : 1 - 7
12345